Phase 3 Otitis Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Completed
Phase 3
Oral prednisolone for acute middle ear infection in children
Acute otitis media in children
Respati Wulansari Ranakusuma60 enrolled1 locationACTRN12618000049279
Recruiting
Phase 3Phase 4
A randomised controlled trial of pneumococcal conjugate vaccines Synflorix and Prevenar13 in sequence or alone in high-risk Indigenous infants (PREV-IX): immunogenicity, carriage and otitis media outcomes
Non-typeable Haemophilus influenzae diseaseOtitis media in Indigenous infantsPneumococcal disease
Menzies School of Health Research425 enrolled1 locationACTRN12610000544077
Completed
Phase 3Phase 4
Azithromycin versus Amoxicillin for Treatment of Acute otitis media in Aboriginal Children (AATAAC)
Acute otitis media in Indigenous children aged 6 months to 6 years
NHMRC330 enrolled1 locationACTRN12609000691246
Recruiting
Phase 3Phase 4
Antibtiotics for Asymptomatic Acute Otitis Media
Acute otitis media without perforation
Menzies School of Health Research300 enrolled1 locationACTRN12608000424303